{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:21:56Z","timestamp":1793154116226,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116352","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T20:07:05Z","timestamp":1710965225000},"page":"116352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles"],"prefix":"10.1016","volume":"269","author":[{"given":"Th\u00e9o","family":"Frazier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reidun","family":"Aesoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Nauton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Herfindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-9622","authenticated-orcid":false,"given":"Fabrice","family":"Anizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116352_bib1","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.bmc.2016.05.032","article-title":"Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c","volume":"24","author":"Esvan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tet.2018.01.017","article-title":"Synthesis and antiproliferative evaluation of glucosylated pyrazole analogs of K252c","volume":"74","author":"Douara","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116352_bib3","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.2174\/092986710793348554","article-title":"Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors","volume":"17","author":"Anizon","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116352_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1158\/1535-7163.MCT-17-1234","article-title":"A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia","volume":"18","author":"Bj\u00f8rnstad","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116352_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1593\/neo.13172","article-title":"Functional role and therapeutic potential of the Pim-1 kinase in colon carcinoma","volume":"15","author":"Weirauch","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2024.116352_bib7","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1074\/jbc.M413155200","article-title":"Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002","volume":"280","author":"Jacobs","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib8","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1021\/jm0504858","article-title":"Structural Basis of inhibitor Specificity of the human Protooncogene Proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase","volume":"48","author":"Bullock","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib9","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1073\/pnas.0708800104","article-title":"A systematic interaction map of validated kinase inhibitors with Ser\/Thr kinases","volume":"104","author":"Fedorov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116352_bib10","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.bmcl.2012.03.098","article-title":"Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives","volume":"22","author":"Aku\u00e9-G\u00e9du","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116352_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2020.152096","article-title":"Synthesis and biological activities of new pyrrolocarbazole-imidazobenzimidazole conjugates","volume":"61","author":"Anizon","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.116352_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/BF02541853","article-title":"Studies on the mechanism of the hydrazine reduction reaction: applications to selected monoethylenic, diethylenic and triethylenic fatty acids of cis configurations","volume":"67","author":"Ratnayake","year":"1990","journal-title":"J. Am. Oil Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116352_bib13","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/chem.201304414","article-title":"Identification and synthesis of macrolide pheromones of the grain beetle oryzaephilus surinamensis and the frog spinomantis aglavei","volume":"20","author":"Hoetling","year":"2014","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.116352_bib14","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1021\/jm101024j","article-title":"Assessment of chemoselective neoglycosylation methods using chlorambucil as a model","volume":"53","author":"Goff","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0040-4020(01)01235-2","article-title":"Synthesis of (\u00b1)-6H-benzofuro[3a,3,2,ef][3]benzazepine: an unnatural analog of (\u2212)-galanthamine","volume":"52","author":"Poschalko","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116352_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116352_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128914","article-title":"Synthesis of new pyrazolo[4,3-a]phenanthridine Pim-1 inhibitors and evaluation of their cytotoxic activity towards the MOLM-13 acute myeloid leukemia cell line","volume":"73","author":"Auvert","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116352_bib18","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.leu.2403899","article-title":"Cell line OCI\/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin","volume":"19","author":"Quentmeier","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2024.116352_bib19","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1016\/j.bmcl.2012.05.098","article-title":"Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases","volume":"22","author":"Dakin","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116352_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"Keeton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116352_bib21","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/s41598-020-60604-3","article-title":"Novel roles of PRK1 and PRK2 in cilia and cancer biology","volume":"10","author":"Patel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116352_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12885-022-09211-1","article-title":"The mixed blessing of AMPK signaling in Cancer treatments","volume":"22","author":"Sadria","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116352_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2015.08.019","article-title":"AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow","volume":"17","author":"Saito","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2024.116352_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110578","article-title":"MARK3 kinase: regulation and physiologic roles","volume":"103","author":"Yang","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2024.116352_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.apsb.2019.09.004","article-title":"PCC0208017, a novel small-molecule inhibitor of MARK3\/MARK4, suppresses glioma progression in vitro and in vivo","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.116352_bib26","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3892\/or.2020.7817","article-title":"Glycogen synthase kinase 3\u03b2 in tumorigenesis and oncotherapy","volume":"44","author":"He","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2024.116352_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12032-022-01899-2","article-title":"GSK3 inhibitor suppresses cell growth and metabolic process in FLT3-ITD leukemia cells","volume":"40","author":"Xia","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejmech.2024.116352_bib28","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-22-0323","article-title":"JAK: not just another kinase","volume":"21","author":"Agashe","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.116352_bib29","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","article-title":"JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model","volume":"124","author":"Degryse","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116352_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"A. J. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116352_bib33","unstructured":"Gaussian 16, Revision C.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. V. Marenich, J. Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. J. Bearpark, J. J. Heyd, E. N. Brothers, K. N. Kudin, V. N. Staroverov, T. A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. P. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2016."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T16:52:40Z","timestamp":1712940760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"alternative-id":["S0223523424002320"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116352","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116352"}}